Reperfusion injury is reduced in skeletal muscle by inhibition of inducible nitric oxide synthase

Journal of Applied Physiology - Tập 94 Số 4 - Trang 1473-1478 - 2003
Li Zhang1, Colin G. Looney1, Wen Qi1, L E Chen1, Anthony V. Seaber1, Jonathan S. Stamler2, James R. Urbaniak1
1Orthopaedic Microsurgery Laboratory, Department of Surgery, and
2Howard Hughes Medical Institute, Pulmonary and Cardiovascular Divisions, Department of Medicine, and Department of Cell Biology, Duke University Medical Center, Durham, North Carolina 27710

Tóm tắt

This study evaluated the effects of the selective inducible nitric oxide synthase (iNOS) inhibitor N-[3-(aminomethyl)benzyl]acetamidine (1400W) on the microcirculation in reperfused skeletal muscle. The cremaster muscles from 32 rats underwent 5 h of ischemia followed by 90 min of reperfusion. Rats received either 3 mg/kg 1400W or PBS subcutaneously before reperfusion. We found that blood flow in reperfused muscles was <45% of baseline in controls but sharply recovered to near baseline levels in 1400W-treated animals. There was a significant ( P < 0.01 to P< 0.001) difference between the two groups at each time point throughout the 90 min of reperfusion. Vessel diameters remained <80% of baseline in controls during reperfusion, but recovered to the baseline level in the 1400W group by 20 min, and reached a maximum of 121 ± 14% (mean ± SD) of baseline in 10- to 20-μm arterioles, 121 ± 6% in 21- to 40-μm arterioles, and 115 ± 8% in 41- to 70-μm arteries ( P < 0.01 to P < 0.001). The muscle weight ratio between ischemia-reperfused (left) and non-ischemia-reperfused (right) cremaster muscles was 193 ± 42% of normal in controls and 124 ± 12% in the 1400W group ( P < 0.001). Histology showed that neutrophil extravasation and edema were markedly reduced in 1400W-treated muscles compared with controls. We conclude that ischemia-reperfusion leads to increased generation of NO from iNOS in skeletal muscle and that the selective iNOS inhibitor 1400W reduces the negative effects of ischemia-reperfusion on vessel diameter and muscle blood flow. Thus 1400W may have therapeutic potential in treatment of ischemia-reperfusion injury.

Từ khóa


Tài liệu tham khảo

10.1152/ajpheart.2001.280.2.H668

10.1042/bj3570593

10.1046/j.0007-1323.2001.01841.x

10.1002/path.845

10.1016/0896-6273(92)90104-L

10.1046/j.1523-1755.2002.00234.x

10.1152/ajpregu.1998.274.3.R822

10.1002/micr.1920110303

10.1002/(SICI)1098-2752(1996)17:6<313::AID-MICR5>3.0.CO;2-I

10.1055/s-2002-19710

10.1097/00006534-199811000-00035

10.1021/bi992046e

10.1016/0891-0618(95)00140-9

10.1074/jbc.272.8.4959

Grant RT., 1966, J Anat, 100, 305

10.1016/S0076-6879(99)00143-3

10.1006/bbrc.2001.5069

10.1161/01.CIR.96.2.667

10.1523/JNEUROSCI.17-23-09157.1997

10.1038/jcbfm.1995.47

10.1055/s-2007-1000071

10.1016/S0014-2999(01)01008-1

10.1016/S1567-5769(01)00087-X

10.1084/jem.174.4.761

10.1016/S0014-2999(97)01163-1

10.1002/(SICI)1098-2752(1998)18:5<299::AID-MICR1>3.0.CO;2-J

10.7326/0003-4819-120-3-199402010-00009

10.1038/sj.bjp.0702549

10.1016/S0003-4975(98)00605-5

10.1016/S0891-5849(01)00485-3

Qi WN, 1999, Microsurgery, 19, 18, 10.1002/(SICI)1098-2752(1999)19:1<18::AID-MICR4>3.0.CO;2-P

10.1152/ajpcell.2001.281.3.C849

10.1161/01.STR.28.6.1283

10.1016/S0092-8674(01)00495-0

10.1152/physrev.2001.81.1.209

10.1097/00005072-199601000-00004

10.1016/S0928-4257(01)00062-6

10.1097/00003086-199701000-00005

10.1006/abbi.1996.0276

10.1016/0014-5793(96)00829-0

Yan Z, 2000, Chin J Traumatol, 3, 76

10.1016/S0006-8993(98)00557-5

10.1096/fj.01-0533com

Thông tin
Thông tin xuất bản

Journal of Applied Physiology

Tập 94 Số 4

1473-1478

Thông tin tác giả